Chronic Kidney Disease Mineral and Bone Disorder Clinical Trial
Official title:
Phosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney Disease
Chronic kidney disease (CKD) affects approximately 26 million Americans with many more at risk for disease development. Elevated serum phosphorus (P) and related abnormalities in P homeostasis due to progressive loss of kidney function are primary driving forces behind cardiovascular dysfunction and mortality in CKD patients. Intestinal P absorption is an critical aspect in P homeostasis but has been understudied, particularly in the early stages of CKD progression. This study aims to determine P absorption in patients with moderate CKD compared to healthy adults.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03960437 -
The Effect of Etelcalcetide on CKD-MBD
|
Phase 2 | |
| Completed |
NCT03937349 -
Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
|
||
| Completed |
NCT03626246 -
Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
|
||
| Active, not recruiting |
NCT03285854 -
Calcium Balance Studies in Children With CKD and on Dialysis
|
||
| Completed |
NCT02697578 -
Artificial Intelligence: a New Alternative to Analyse CKD-MBD in Hemodialysis
|
||
| Active, not recruiting |
NCT04019379 -
Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease
|
N/A |